Clinical trial
Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer
NCT00054574 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00054574 |
|---|---|
| Title | Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer |
| Official title | A Clinical Trial Evaluating The Safety And Efficacy Of ABX-EGF In Patients With Hormone Resistant Prostate Cancer With Elevated PSA Without Metastasis |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Biological |
| Interventions | panitumumab |
| Start date | Nov 1, 2002 |
| Primary completion | Sep 1, 2003 |
| Completion | Feb 1, 2004 |
| First posted | Feb 6, 2003 |
| Last update posted | Aug 3, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: